**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 302-95-4 |Deoxycholic Acid Sodium salt | >98 | 206-132-7 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 37
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to respiratory system.The
toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. Can produce delayed
pulmonary edema.
Chronic:
Prolonged or repeated exposure may cause adverse reproductive
effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
For small fires, use water spray, dry chemical, carbon dioxide or
chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 302-95-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: almost white
Odor: none reported
pH: Not available.
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 177 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C24H39NaO4
Molecular Weight: 414.55
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
High temperatures, incompatible materials, dust generation.
Incompatibilities with Other Materials:
Strong oxidizers.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, toxic fumes of sodium oxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 302-95-4: FZ2250000
LD50/LC50:
CAS# 302-95-4: Oral, mouse: LD50 = 1050 mg/kg; Oral, rat: LD50 =
1370 mg/kg.
Carcinogenicity:
Deoxycholic Acid Sodium salt -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 37 Irritating to respiratory system.
Safety Phrases:
S 20 When using do not eat or drink.
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 302-95-4: 1
Canada
CAS# 302-95-4 is listed on Canada's DSL List.
CAS# 302-95-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 302-95-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 7/14/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Hematoxylin
| 517-28-2 |
|
tert-Butyl nitrite, tech., 90%
| 75-65-0 |
|
Indigo Carmine
| 860-22-0 |
|
Cis-2-Hydroxy-1-Cyclopentanecarboxylic Acid, 99%
| 17502-28-2 |
|
2,4-Dihydroxybenzophenone, 99%
| 131-56-6 |
|
Tetramethylammonium methyl sulfate
| 811-92-7 |
|
4-Chloro-3-nitrobenzotrifluoride, 98%
| 121-17-5 |
|
Malachite Green Oxalate
| 2437-29-8 |
|
Phenylselenyl chloride, 98%
| 5707-04-0 |
|
Docosanedioic Acid, 94+% (GC)
| 505-56-6 |
|
Methyl Green
| 7114-03-6 |
|
Alpha,4-Dimethylbenzylalcohol, 98%
| 536-50-5 |
|
Ethylene/ethyl acrylate copolymer
| 9010-86-0 |
|
Methyl Orange
| 547-58-0 |
|
Amido Black 10B
| 1064-48-8 |
|
1,5-Diamino-3-Oxapentane, 98%
| 2752-17-2 |
|
Neutral Red
| 553-24-2 |
|
Anthracene-9-Carboxylic Acid, 99%
| 723-62-6 |
|
4-Chloro-2-Nitrobenzoic Acid, 97%
| 6280-88-2 |
|
1,4-Butanediol-d10, 99+
| 71760-76-4 |
|
D-Alpha-Tocopherylquinone, 99% (UV-Vis)
| 7559-04-8 |
|
DL-Glutamic Acid Monohydrate, 99%
| 617-65-2 |
|
Diethyl(2-oxopropyl)phosphonate, 96%
| 1067-71-6 |
|
Orange G
| 1936-15-8 |
|
Orcein (Synthetic)
| 1400-62-0 |
|
1,2-Benzenedisulfonic Acid, Dipotassium Salt, Monohydrate
| 5710-54-3 |
|
10-Methylanthracene-9-Carboxaldehyde
| 7072-00-6 |
|
Triphenylphosphonium Bromide,99%
| 6399-81-1 |
|
PAN
| 85-85-8 |
|
4-Mercaptopyridine, 96%(titr.)
| 4556-23-4 |
|
1,10-Phenanthroline monohydrate
| 66-71-7 |
|
Julolidine, 98%
| 479-59-4 |
|
3-Hydroxy-2-Methyl-4-Quinolinecarboxylic Acid, 99%
| 117-57-7 |
|
3-(2-Furyl)acrolein, 99%
| 623-30-3 |
|
Pyruvic Acid Sodium Salt
| 113-24-6 |
|
5,5-Diphenylhydantoin, 99+%
| 57-41-0 |
|
DL-Pipecolinic Acid, 99%
| 4043-87-2 |
|
2-Hydroxy-3-methoxybenzyl alcohol, 95%
| 4383-05-5 |
|
1,2-Diphenoxyethane, 99%
| 104-66-5 |
|
Rose Bengal Disodium Salt
| 632-69-9 |
|
1,3,5-Benzenetrisulfonic acid trisodium salt, trihydrate
| 43052-65-9 |
|
Safranin O
| 477-73-6 |
|
n-Acetyl-dl-tryptophan, 99+%
| 87-32-1 |
|
Veratrole, 99+%
| 91-16-7 |
|
Deoxycholic Acid Sodium Salt, 97% (Titr.)
| 302-95-4 |
|
Sodium Diethyldithiocarbamate Trihydrate
| 20624-25-3 |
|
Sudan III
| 85-86-9 |
|
Sudan IV
| 85-83-6 |
|
Sudan Black B
| 4197-25-5 |
|
Thenoyltrifluoroacetone
| 326-91-0 |
|
|